NCT01077297 - Tezosentan in Pulmonary Arterial Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

September 30, 2011

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Tezosentan

single infusion of tezosentan 5mg/h over 30 min corresponding to 2.5 mg

Trial Locations (5)

Washington University School of Medicine, St Louis

Baylor College of Medicine, Houston

Hopital Antoine Béclère, Paris

University Hospital of Basel, Clinic of Pneumology, Basel

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne